1/13
04:05 pm
fhtx
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
Medium
Report
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
1/9
10:20 pm
fhtx
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
High
Report
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
12/20
01:30 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at
Wall Stre
High
Report
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at
Wall Stre
12/19
05:58 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
12/18
07:11 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
High
Report
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
12/6
01:36 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was downgraded by analysts at
Wall St
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) was downgraded by analysts at
Wall St
12/3
07:01 pm
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Stifel Nicolaus.
11/29
12:31 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at
Wall Stre
Medium
Report
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at
Wall Stre
11/5/2025
07:00 am
fhtx
foghorn therapeutics inc.
BEAT
Report
16.3%
foghorn therapeutics inc.
5/14/2025
07:00 am
fhtx
foghorn therapeutics inc.
IN-LINE
Report
-3.3%
foghorn therapeutics inc.
1/15
05:00 pm
fhtx
Form 4 Foghorn Therapeutics For: Jan 13 Filed by: Flagship Pioneering Fund VII General Partner LLC
Medium
Report
Form 4 Foghorn Therapeutics For: Jan 13 Filed by: Flagship Pioneering Fund VII General Partner LLC
1/13
05:09 pm
fhtx
Form SCHEDULE 13D/A Foghorn Therapeutics Filed by: Flagship Ventures Fund V, L.P.
Medium
Report
Form SCHEDULE 13D/A Foghorn Therapeutics Filed by: Flagship Ventures Fund V, L.P.
1/12
04:49 pm
fhtx
Form 424B5 Foghorn Therapeutics
Medium
Report
Form 424B5 Foghorn Therapeutics
1/12
08:51 am
fhtx
Form 8-K Foghorn Therapeutics For: Jan 09
High
Report
Form 8-K Foghorn Therapeutics For: Jan 09
12/4
07:00 am
fhtx
Form 8-K Foghorn Therapeutics For: Dec 03
Low
Report
Form 8-K Foghorn Therapeutics For: Dec 03
11/17
04:01 pm
fhtx
Form 4 Foghorn Therapeutics For: Nov 14 Filed by: Humer Kristian
Medium
Report
Form 4 Foghorn Therapeutics For: Nov 14 Filed by: Humer Kristian
11/7
04:34 pm
fhtx
Form 8-K Foghorn Therapeutics For: Nov 07
Low
Report
Form 8-K Foghorn Therapeutics For: Nov 07
11/5
07:04 am
fhtx
Form 10-Q Foghorn Therapeutics For: Sep 30
High
Report
Form 10-Q Foghorn Therapeutics For: Sep 30
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register